| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 584.64B | 580.34B | 562.90B | 517.74B | 432.13B | 386.51B |
| Gross Profit | 142.31B | 138.93B | 125.66B | 112.07B | 96.89B | 96.57B |
| EBITDA | 77.36B | 75.09B | 64.74B | 52.76B | 41.53B | 44.18B |
| Net Income | 32.16B | 30.42B | 32.06B | 13.93B | 8.47B | 11.46B |
Balance Sheet | ||||||
| Total Assets | 672.50B | 693.74B | 656.66B | 540.91B | 480.76B | 431.91B |
| Cash, Cash Equivalents and Short-Term Investments | 43.46B | 60.79B | 63.94B | 36.27B | 25.86B | 36.28B |
| Total Debt | 109.44B | 117.16B | 87.78B | 114.03B | 90.28B | 73.23B |
| Total Liabilities | 282.72B | 302.75B | 282.78B | 270.01B | 230.82B | 197.34B |
| Stockholders Equity | 345.87B | 347.05B | 329.99B | 230.68B | 215.23B | 202.25B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -26.21B | 24.83B | -2.60B | -14.14B | 16.80B |
| Operating Cash Flow | 0.00 | 39.30B | 63.18B | 28.33B | 12.88B | 35.82B |
| Investing Cash Flow | 0.00 | -58.82B | -44.85B | -26.57B | -30.20B | -19.33B |
| Financing Cash Flow | 0.00 | 14.23B | 2.14B | 8.83B | 5.20B | -7.02B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥487.88B | 8.10 | 9.63% | 2.12% | 3.05% | -16.11% | |
72 Outperform | ¥6.71T | 26.86 | 32.32% | 0.91% | 27.53% | 137.34% | |
71 Outperform | ¥10.81T | 21.58 | 9.29% | 1.19% | 4.62% | 40.65% | |
63 Neutral | ¥1.50T | 19.95 | 12.05% | 1.50% | 5.44% | -5.19% | |
61 Neutral | $1.95T | 7.80 | 10.06% | 1.21% | 10.52% | 60.75% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% |